Director, Cell Therapy Manufacturing Facility
MedStar Georgetown University Hospital
Washington, District of Columbia
Wanxing Cui, MD, PhD, CABP(H), is the Director of the Cell Therapy Manufacturing Facility at MedStar Georgetown University Hospital. Dr. Cui has extensive expertise in cGMP cell therapy manufacturing, quality management systems, and multi-standard accreditation (AABB, FACT, CAP). She serves as an AABB CTSCC Member and AABB CABP Commission Member. Recent activities include chairing "Quality Agreements in Cell Therapy" at the 2025 AABB Annual Meeting, speaking on the AABB eCast "AI and Its Use in Biotherapies" (March 2026), and serving as Director/Moderator for the AABB eCast on IDM Testing (June 2026).
Disclosure information not submitted.